Tillman Departs: Device Evaluation Director To Leave FDA March 26
This article was originally published in The Gray Sheet
Executive Summary
Office of Device Evaluation Director Donna-Bea Tillman will step down March 26 to join Microsoft's health unit, she said in a March 1 email to her staff
You may also be interested in...
People In Brief
McCoy exits J&J. Philips Healthcare CEO moves to Quest Diagnostics. More people briefs
News In Brief
FDA Office of Device Evaluation director
News In Brief
FDA Office of Device Evaluation director